Gene · 10403
Papers2,370
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,370
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methodology to Create Auxin-Inducible Degron Tagging System to Control Expression of a Target Protein in Mammalian Cell Lines. | Bio Protoc | 2024 | 38268977 | PubTator, text mining | PubMed |
| XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer. | PeerJ | 2024 | 38250721 | PubTator, text mining | PubMed |
| Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response. | Metabolites | 2024 | 38248854 | PubTator, text mining | PubMed |
| m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation. | Transl Oncol | 2024 | 38242006 | PubTator, text mining | PubMed |
| NUSAP1 promotes pancreatic ductal adenocarcinoma progression by drives the epithelial-mesenchymal transition and reduces AMPK phosphorylation. | BMC Cancer | 2024 | 38229038 | PubTator, text mining | PubMed |
| Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients. | Cancer Cell Int | 2024 | 38195567 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma. | PLoS One | 2024 | 38181024 | PubTator, text mining | PubMed |
| Effectiveness of a multidisciplinary treatment with youth-initiated mentoring for youths with mental health needs from multi-problem families: a quasi-experimental study. | BMC Public Health | 2024 | 38166901 | PubTator, text mining | PubMed |
| An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes. | Emerg Microbes Infect | 2024 | 37994664 | PubTator, text mining | PubMed |
| PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation. | J Clin Invest | 2024 | 37934606 | PubTator, text mining | PubMed |
| DNA strand breaks at centromeres: Friend or foe? | Semin Cell Dev Biol | 2024 | 37872040 | PubTator, text mining | PubMed |
| In-silico studies of 2-aminothiazole derivatives as anticancer agents by QSAR, molecular docking, MD simulation and MM-GBSA approaches. | J Biomol Struct Dyn | 2024 | 37811574 | PubTator, text mining | PubMed |
| Effects of targeting highly expressed in cancer protein 1 (Hec1) inhibitor INH 1 in breast cancer cell lines In Vitro. | Cell Mol Biol (Noisy-le-grand) | 2023 | 38279468 | PubTator, text mining | PubMed |
| Gross Chromosomal Rearrangement at Centromeres. | Biomolecules | 2023 | 38254628 | PubTator, text mining | PubMed |
| NamiRNA-mediated high expression of KNSTRN correlates with poor prognosis and immune infiltration in hepatocellular carcinoma. | Contemp Oncol (Pozn) | 2023 | 38239867 | PubTator, text mining | PubMed |
| Biomarkers in Cancer Detection, Diagnosis, and Prognosis. | Sensors (Basel) | 2023 | 38202898 | PubTator, text mining | PubMed |
| Risk factors analysis and survival prediction model establishment of patients with lung adenocarcinoma based on different pyroptosis-related gene subtypes. | Eur J Med Res | 2023 | 38111060 | PubTator, text mining | PubMed |
| Enhanced Redox Electrocatalysis in High-Entropy Perovskite Fluorides by Tailoring d-p Hybridization. | Nanomicro Lett | 2023 | 38108921 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
| Microgravity triggers ferroptosis and accelerates senescence in the MG-63 cell model of osteoblastic cells. | NPJ Microgravity | 2023 | 38104197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10403/papers?page=7